Fitell Corporation Announces Closing of Registered Direct Offering for up to $10.0 Million
February 10, 2025 16:15 ET
|
Fitell Corporation
$4.0 million upfront with up to an additional $6.0 million of gross proceeds upon the exercise in full for cash of warrants TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Fitell...
Fitell Corporation Announces Updated Registered Direct Offering for up to $10.0 Million
February 10, 2025 08:45 ET
|
Fitell Corporation
$4.0 million upfront with up to an additional $6.0 million of gross proceeds upon the exercise in full for cash of warrants TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Fitell...
SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market
February 03, 2025 16:05 ET
|
SeaStar Medical Holding Corporation
DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its previously announced registered direct offering,...
Houston American Energy Corp. Announces $4,420,000 Registered Direct Offering.
January 22, 2025 08:30 ET
|
Houston American Energy Corp.
HOUSTON, TX, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Houston American Energy Corp. (NYSE American: HUSA) (the “Company”) today announced that it has entered into a definitive agreement with several...
LIXTE Biotechnology Announces Closing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
July 20, 2023 16:05 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, July 20, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced the closing of its previously announced...
LIXTE Biotechnology Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
July 18, 2023 08:00 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, July 18, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced it has entered into a securities purchase...
Palisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
April 03, 2023 08:30 ET
|
Palisade Bio, Inc.
Carlsbad, CA, April 03, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is...
Aridis Pharmaceuticals Announces $2.28 Million Registered Direct Offering of Common Stock
March 14, 2023 09:45 ET
|
Aridis Pharmaceuticals, Inc.
Los Gatos, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company, today announced that it has entered into a definitive agreement for...
Streamline Health® Announces Strategic Alignment and Closing of Registered Direct Offering of Common Stock
October 27, 2022 16:05 ET
|
Streamline Health Solutions, Inc.
The Company closed the previously announced registered direct offering of common stock for gross proceeds of approximately $8.3 million; more than 30% was raised from insidersBen Stilwill appointed...
Streamline Health® Announces Registered Direct Offering of Common Stock
October 25, 2022 08:30 ET
|
Streamline Health Solutions, Inc.
Atlanta, GA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...